2 results
Approved WMOPending
To document that 8 weeks treatment with ledipasvir-sofosbuvir is effective in chronic HCV genotype 4 patients without cirrhosis.
Approved WMOCompleted
The purpose of this studie is to evaluate the bioequivalence of canagliflozin.